Product Description
Overall, the global stopcock market was valued at $175.1 million in 2023, a 5.7% increase from $165.7 million in 2022. This is expected to increase over the forecast period at a CAGR of 4.9% to reach $245.5 million. Currently, the global stopcock market is dominated by Becton Dickinson (BD), and B. Braun.
Throughout this medical market research, we analyzed over 20 stopcock companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL STOPCOCK MARKET INSIGHTS 
Stopcocks are facing competition from emerging needleless connectors, which are being recognized as alternative technologies in the market. Needleless connectors offer several benefits, including enhanced infection control, decreased fluid wastage, and improved precision in fluid management. These connectors are progressively becoming more widely available and adopted, and their presence is exerting an influence on the traditional stopcock market segments. As needleless connectors continue to gain popularity, they are progressively supplanting conventional stopcocks in specific applications and healthcare environments.
GLOBAL STOPCOCK MARKET SHARE INSIGHTS
In 2023, Becton Dickinson (BD) emerged as the dominant force in the worldwide stopcock market, firmly securing its position as the industry leader. BD proudly presents two key offerings: the Alaris® lipid-resistant, 3-way stopcock and an alternative latex- and PVC-free variant of the same essential medical device. BD’s commanding presence extends to North America and Western Europe, where it stands as the second-largest player, reinforcing its global stronghold. Beyond these regions, BD enjoys a robust market presence, firmly entrenched in numerous regional markets surveyed.
B. Braun, in the same year, clinched the position of the second-most influential competitor in the global stopcock arena. Renowned for its infusion pump manufacturing prowess, B. Braun adopts a unique approach by bundling its stopcock devices with other medical equipment. Many hospitals gravitate towards a one-stop-shop approach, opting to procure the majority of their infusion products from a single manufacturer. This strategic advantage significantly bolsters B. Braun’s position in the stopcock market, especially in Western Europe, where it consistently excels across a diverse range of medical devices.
The lower echelons of the global stopcock market landscape are predominantly occupied by smaller, localized contenders. These nimble players specialize in crafting straightforward, cost-effective products tailored for hospital use. However, their market share pales in comparison to industry giants capable of bundling stopcock sales with a comprehensive suite of infusion therapy products. Notably, companies like B. Braun and Becton Dickinson, among others, reign supreme in this league, leveraging their comprehensive product portfolios to maintain a commanding presence.
MARKET SEGMENTATION SUMMARY
- Stopcock Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
